Home Compare ERF.PA vs HCA
Stock Comparison · Comparison

Eurofins Scientific vs HCA Healthcare: Which Stock Looks Stronger in 2026?

HCA Healthcare holds the cleaner structural position, with the lead spread across profitability and valuation. Eurofins Scientific SE does not offset that deficit through any equally strong structural edge elsewhere. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both profitability and valuation materially support the lead. The overall score gap is 29 points in favour of HCA Healthcare, Inc..

Trajectory Similarity
0.73
Similar
Peer-set rank: #9
within Eurofins Scientific SE's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

Most of the shared profile comes through margin consistency and revenue stability.

Similarity drivers
margin consistencyrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
ERF.PA
Eurofins Scientific SE
41
Peer-Score
Signal qualityHigh
vs
HCA
HCA Healthcare, Inc.
70
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: ERF.PA vs HCA Profitability 19 72 Stability 54 58 Valuation 49 84 Growth 50 59 ERF.PA HCA
Gap Ranking
#1 Profitability +53
#2 Valuation +35
#3 Growth +9
#4 Stability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ERF.PA and HCA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ERF.PAHCA Relative valuation Structural strength

HCA Healthcare, Inc. looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, HCA Healthcare, Inc. ranks near the top of the group; Eurofins Scientific SE sits in the weaker half.
Valuation
On valuation, the same pattern holds: both are strong, but HCA Healthcare, Inc. still leads clearly.
Profitability — Dominant Gap
ERF.PA
19
HCA
72
Gap+53in favour of HCA

Capital efficiency adds support, with a 14.8-point ROIC advantage.

What keeps the gap from being one-sided

Eurofins Scientific SE still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the ERF.PA vs HCA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-valuation comparisons

Explore how ERF.PA and HCA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.